News
8h
Sportschosun on MSNAhn Jae Hong, are you retiring again? A flood of makeup and acting in 'SNL 7'...'This is your specialty'Actor Ahn Jae-hong once again added the title of 'End of Retirement' through 'SNL Korea Season 7'. Ahn Jae-hong, who was the ...
1d
Lifestyle Asia on MSNDecoding the tragic ending of 'Dear Hongrang': Lee Jae-wook's final trialIn its haunting finale episode "Forever and After," K-drama Dear Hongrang delivers a poignant ending steeped in sorrow, ...
Eli Lilly & Co.’s stock soared 14% Thursday, to put it on track for its biggest one-day gain in about 25 years, after the drugmaker reported positive results from a late-stage trial of a GLP-1 ...
The 61st Baeksang Arts Awards are almost here! As one of Korea’s ‘big three’ film honours alongside the Daejong International Film Awards and the Blue Dragon Film Awards, this particular ...
A shocking new side effect known as “Ozempic mouth” may be affecting some Hollywood celebrities using the weight loss drug, a report has stated. A New York-based cosmetic dermatologist told ...
The weight loss medication Ozempic has become the most talked-about drug in Hollywood, with several celebrities like Kyle Richards and Garcelle Beauvais denying that they’ve taken it to shed pounds.
Ahn Jae-hong, who is willing to undergo drastic image changes, including weight loss and gain for his roles, is expected to give rise to another legendary character in the film 'High Five' by ...
Samples of two weight ... Hong Kong on Jan. 11, 2023, and expiring on Jan. 11, 2026. It was imported and distributed by EU YB Joint Stock Company in Yen Bai City in northern Vietnam. A batch of Best ...
Upcoming film “Hi-5” has unveiled new stills of Ahn Jae Hong ahead of its premiere! “Hi-5” is a comic action adventure that tells the story of five individuals who unexpectedly gain ...
Upcoming film “Hi-5” has unveiled new stills of Ahn Jae Hong ahead of its premiere! “Hi-5” is a comic action adventure that tells the story of five individuals who unexpectedly gain different ...
Weight loss drugs, like brand names Wegovy and Zepbound, continue to soar in popularity, and now researchers in Dallas want to know if this class of drugs, GIP/GLP-1 receptor agonists, might be a ...
Christopher Groux is an editor, writer and accessibility advocate. Before joining the Forbes Health team, he covered Accessibility at Reviewed and gaming at Inverse and Newsweek. When he’s not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results